Latest news
Loading news…
Argenica Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Nedlands, Western Australia, Australia Founded 2019 1-10 employees For Profit
Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Ticker
AGN
ASX - Australian Securities Exchange
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- AGN
- Exchange
- ASX - Australian Securities Exchange
- IPO date
- Jun 11, 2021
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2019
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 20
- HQ
- Nedlands, Western Australia, Australia
- Region
- Asia-Pacific (APAC), Australasia
- Exit date
- Jun 11, 2021
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- 0
- Trend (30d)
- -0.3
- Trend (90d)
- -0.3
- Last leadership hire
- Dec 29, 2025
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Argenica Therapeutics
Loading news…
FAQs about Argenica Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.